Eczema trials recruiting in Maryland

All Eczema trials nationally

Cities in Maryland

Recruiting trials in Maryland

• A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up
  NCT06732414 · Phase: Not specified · Ages: 3 Years to 100 Years · Sex: All (male and female) · Maryland: Bethesda
• A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
  NCT07003425 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Rockville
• A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
  NCT07599813 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Maryland: Pasadena
• A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
  NCT05995964 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Hunt Valley
• A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
  NCT06461897 · Phase: Phase 3 · Ages: 2 Years to 11 Years · Sex: All (male and female) · Maryland: Lanham, Rockville
• Cardamom and Topical Roseomonas in Atopic Dermatitis
  NCT06096857 · Phase: Phase 2 · Ages: 2 Years to 100 Years · Sex: All (male and female) · Maryland: Bethesda
• Dupilumab De-escalation in Pediatric Atopic Dermatitis
  NCT06116526 · Phase: Phase 4 · Ages: 1 Year to 17 Years · Sex: All (male and female) · Maryland: Baltimore
• Effects of Treatments on Atopic Dermatitis
  NCT01631617 · Phase: Phase 2 · Ages: 2 Years to 50 Years · Sex: All (male and female) · Maryland: Bethesda
• Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
  NCT07262983 · Phase: Phase 1 · Ages: 12 Years to 120 Years · Sex: All (male and female) · Maryland: Bethesda
• Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
  NCT07645820 · Phase: Not specified · Ages: 12 Years to 89 Years · Sex: All (male and female) · Maryland: Rockville
• Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis
  NCT03835767 · Phase: Phase 2 · Ages: 3 Years to 21 Years · Sex: All (male and female) · Maryland: Bethesda
• Metabolic Profiling of Immune Responses in Immune-mediated Diseases
  NCT04864886 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · Maryland: Bethesda
• Natural History and Genetics of Food Allergy and Related Conditions
  NCT02504853 · Phase: Not specified · Ages: 1 Day to 99 Years · Sex: All (male and female) · Maryland: Bethesda
• Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
  NCT06988605 · Phase: Not specified · Ages: 12 Years and older · Sex: All (male and female) · Maryland: Columbia, Glenn Dale, Rockville
• Registry for Systemic Eczema Treatments
  NCT06136767 · Phase: Not specified · Ages: 1 Year to 26 Years · Sex: All (male and female) · Maryland: Baltimore
• Studies of Skin Microbes in Healthy People and in People With Skin Conditions
  NCT00605878 · Phase: Not specified · Ages: 2 Years to 100 Years · Sex: All (male and female) · Maryland: Bethesda